Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021
Aleksandra Sochacka-Ćwikła, Marcin Mą̨czyński, Andrzej Regiec
Molecules (2022) Vol. 27, Iss. 7, pp. 2259-2259
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 299-299
Open Access | Times Cited: 141
VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 53
Drug Delivery Systems for Localized Cancer Combination Therapy
Ryan Woodring, Elizabeth G. Graham-Gurysh, Eric M. Bachelder, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 3, pp. 934-950
Open Access | Times Cited: 30
Novel hybrid structures based on 4-Chlorobenzenesulfonyl and 1,2,3-triazoles: Synthesis, in vitro biological activities and in silico studies
Mustafa Çeşme, Sultan Onur, Elif Aksakal, et al.
Journal of Molecular Liquids (2024) Vol. 409, pp. 125501-125501
Closed Access | Times Cited: 9
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 8
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Novel cyanochalcones as potential anticancer agents: apoptosis, cell cycle arrest, DNA binding, and molecular docking studies
Mohamed A. Ragheb, Hanan E. Abdelrashid, Emad M. Elzayat, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 4
Altered cancer metabolism and implications for next-generation CAR T-cell therapies
Rishab Ramapriyan, Vivasvan S. Vykunta, Gust Vandecandelaere, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108667-108667
Closed Access | Times Cited: 4
Targeting hexokinase 2 for oral cancer therapy: structure-based design and validation of lead compounds
Purbali Chakraborty, Syeda Lubna, Shouvik Bhuin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Synthesis, Anticancer Activity and Molecular Docking Studies of Novel N-Mannich Bases of 1,3,4-Oxadiazole Based on 4,6-Dimethylpyridine Scaffold
Małgorzata Strzelecka, Teresa Glomb, Małgorzata Drąg‐Zalesińska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11173-11173
Open Access | Times Cited: 13
Cancer-Fighting Isoxazole Compounds: Sourcing Nature's Potential and Synthetic Advancements- A Comprehensive Review
Udita Malik, Dilipkumar Pal
ES Food & Agroforestry (2023)
Open Access | Times Cited: 7
Isoxazole compounds: unveiling the synthetic strategy, In-silico SAR & Toxicity studies and future perspective as PARP inhibitor in cancer therapy
Udita Malik, Dilipkumar Pal
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116898-116898
Closed Access | Times Cited: 2
Small Molecule Drug Design
Rajdeep Dey, Udit Chaube, Hardik Bhatt, et al.
Elsevier eBooks (2024)
Closed Access | Times Cited: 2
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
Gabriele Conti, Federica D’Amico, Marco Fabbrini, et al.
Genes (2022) Vol. 14, Iss. 1, pp. 55-55
Open Access | Times Cited: 12
New Oxazolo[5,4-d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research
Aleksandra Sochacka-Ćwikła, Marcin Mą̨czyński, Żaneta Czyżnikowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11694-11694
Open Access | Times Cited: 9
Immunological landscape of solid cancer: Interplay between tumor and autoimmunity
Ajay Singh, Phaneendra K. Duddempudi, Divya Kenchappa, et al.
International review of cell and molecular biology (2024), pp. 163-235
Closed Access | Times Cited: 1
Targeting MYC with protein drugs
Jumi A. Shin
Progress in molecular biology and translational science (2024), pp. 1-23
Closed Access | Times Cited: 1
Focused ultrasound-mediated small-molecule delivery to potentiate immune checkpoint blockade in solid tumors
Qiuyu Wu, Yuanhang Xia, Xiaohe Xiong, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Synthesis and structural proof of novel oxazolo[5,4-d]pyrimidine derivatives as potential VEGFR2 inhibitors. In vitro study of their anticancer activity
Aleksandra Sochacka-Ćwikła, Andrzej Regiec, Żaneta Czyżnikowska, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107958-107958
Open Access | Times Cited: 1
Synthesis of Novel N-Methylmorpholine-Substituted Benzimidazolium Salts as Potential α-Glucosidase Inhibitors
Imran Khan, Furqan Ahmad Saddique, Sana Aslam, et al.
Molecules (2022) Vol. 27, Iss. 18, pp. 6012-6012
Open Access | Times Cited: 6
In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer
Sunil Kumar, Monu Kumar Shukla, Iqra Ali, et al.
Molecular Simulation (2023) Vol. 49, Iss. 17, pp. 1614-1631
Closed Access | Times Cited: 3
ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications
Flavia Linguanti, Elisabetta Abenavoli, Raffaella Calabretta, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5886-5886
Open Access | Times Cited: 2
Prostate Cancer
Mohd Adnan, Himavarshitha Babbur, Sai Sandeep Annamaraju, et al.
(2024), pp. 157-170
Closed Access
Multifaceted perspectives of detecting and targeting solid tumors
Abhishek Bhattacharya, Anjan Kr. Dasgupta
International review of cell and molecular biology (2024), pp. 1-66
Closed Access
Design, Synthesis, and Evaluation of Trihalomethyl Ketone Derivatives of Neocarzilin A as Improved Antimetastatic Agents
Noah M. Moriarty, Annaleigh Benton, Lauren E. Gartenhaus, et al.
ACS Bio & Med Chem Au (2024) Vol. 4, Iss. 6, pp. 331-341
Open Access
Page 1 - Next Page

Scroll to top